Dian Diagnostics Group Co., Ltd.
迪安诊断
300244
Shenzhen Stock Exchange
Company Profile
Dian Diagnostics possesses core competencies in the following four areas: (i) Leveraging an integrated "Service + Product + Digital" solution that precisely aligns with the development trends of China's medical market, the company has evolved from a single test outsourcing provider into a one-stop comprehensive service partner covering the entire lifecycle of medical institutions. (ii) Having built an integrated "R&D, Manufacturing, Sales, and Testing" industry chain, the company achieves efficient synergies across upstream core technologies, a midstream nationwide service network, and downstream health management, significantly enhancing its risk resistance capabilities and long-term competitive advantages. (iii) Continuously driving technological innovation across multiple technology platforms such as high-throughput sequencing and mass spectrometry, the company fully implements international quality standards including ISO15189 and CAP, and its laboratory management and technical capabilities have received multiple national-level recognitions. (iv) Leveraging extensive test menu items and massive medical testing data accumulated from serving over 22,000 healthcare institutions, along with its digital platform and AI large model initiatives, the company has built a core barrier in digital intelligence and is steadily upgrading toward becoming a leading provider of intelligent diagnostic solutions.
Full description
As an innovative leader in China's medical diagnostics field, DIAN Diagnostics focuses on third-party diagnostic services as its core business, positioning itself as a pioneer in intelligent diagnostic solutions. Leveraging advanced testing technologies and intelligent means, the company is committed to providing healthcare institutions at all levels (including general hospitals, specialized hospitals, community health service centers/stations, township (town) health centers, physical examination centers, and centers for disease control and prevention) with disease-oriented, integrated "Service + Product + Digital" solutions, addressing patients’ comprehensive clinical diagnosis and treatment needs. The company’s main businesses cover medical diagnostic services, diagnostic technology R&D, diagnostic product manufacturing and sales, forensic identification, and health management. The company is dedicated to building a complete ecosystem covering the entire lifecycle of medical diagnostics, to meet the diverse needs of healthcare institutions at all levels across various stages and scenarios. When healthcare institutions have in-house testing needs, the company relies on its nationwide distribution network for diagnostic products and three major proprietary product lines (covering equipment, reagents, consumables, and technical support) to provide foundational service capabilities supported by a large-scale supply chain. When healthcare institutions have outsourced testing needs, the company leverages its national chain of independent medical laboratories and a wide range of testing items to provide accurate and timely medical diagnostics and research outsourcing services, achieving large-scale testing service capabilities. When healthcare institutions need to improve in-house efficiency and reduce costs, the company adopts cooperative co-construction and precision center models to enhance management efficiency through professional operations, achieve effective cost reduction via a large-scale supply chain, expand testing capabilities with a comprehensive range of items, and enhance academic influence with leading technology platforms. Through comprehensive "AI + Digitalization" empowerment, the company drives all needs and upgrades the entire ecosystem, realizing product intelligence, ICL automation, co-construction collaboration, precision center efficiency, precise health management, and medical data digitization.